-
Document de presse | 2024.02.14
Smoking has long-term effects on the immune system
Like other factors such as age, sex and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. For...
-
News | 2023.06.06
HIV-AIDS: natural killer cells that target HIV
African green monkeys are able to live while being infected with the simian immunodeficiency virus (SIV) without ever developing AIDS. Their hint? Directly eliminate infected cells, without causing an inflammatory reaction that the virus could use to its advantage.
-
Fiche maladie | 2021.07.22
Lyme disease (Lyme borreliosis)
Lyme disease, also known as Lyme borreliosis, is a tick-borne disease. It is the most widespread vector-borne disease in the entire northern hemisphere. Its incidence continues to rise at global level as a result of demographic and environmental factors, including climate change.
-
Événement | 2022.11.24
Colloquium for the centenary of Alphonse Laveran’s death
The French Defence Central Health Service ("Service de Santé des Armées" or SSA) pay a scientific and historical tribute to Alphonse Laveran, with a symposium on November 24, 2022 at the Val-de-Grâce School, to mark the centenary of his death. This event is organized with the scientific sponsorship of the Académie nationale de médecine (National Academy of Medicine) and the Institut Pasteur in...
-
Document de presse | 2024.05.30
Indian Ocean surface temperature could help anticipate dengue outbreaks
Although dengue outbreaks cannot be prevented, it is possible to anticipate them. An international research team including scientists from the Institut Pasteur and Beijing Normal University in China has recently identified a global climate indicator that may help improve predictions about the magnitude of dengue outbreaks several months in advance. This indicator, which can be used for any world...
-
News | 2022.08.05
Our own RNA triggers an immune response to viral infections
An immune receptor normally known for identifying viral RNA is also capable of binding to cellular RNA to induce immune defenses. This mechanism could trigger immunity against viruses before they become detectable.
-
News | 2024.07.04
How coronavirus HKU1 forces its way into cells
Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.
-
Portrait | 2024.05.21
Philippe Bousso: harnessing immune responses to combat cancer
Philippe Bousso, an immunologist and technophile with insatiable curiosity, is constantly tackling new challenges in his efforts to combat cancer. Like the characters in the sci-fi film Fantastic Voyage, he and his team use cutting-edge in vivo technologies to observe the ways in which the immune system wages war on cancer cells. For Philippe, creativity and innovation pave the way for new...
-
Fiche maladie | 2015.12.28
Shigellosis
Shigellosis, also known as bacillary dysentery, is an infectious bowel disease caused by a group of bacteria known by the name of Shigella. Infection is mainly characterized by severe diarrhea, often containing blood, together with abdominal cramps and fever. It mainly affects preschool age children, but can also occur in adults.
-
Document de presse | 2025.02.12
Mpox: a better understanding of tecovirimat resistance
A virus originally found in animals, mpox – which causes the disease of the same name – is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic areas in Central and West Africa. Two hundred and fifteen cases of mpox infection were reported to Santé publique France in 2024. Tecovirimat is the drug most commonly used to treat patients infected...